← All trials
NCT05093166
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2021
- Primary completion
- Mar 31, 2023
- Completion date
- Mar 31, 2023
- First posted
- Oct 26, 2021
- Last posted
- Nov 15, 2021
- Enrollment
- 8
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Holostem Terapie Avanzate s.r.l.Lead sponsor
- University of Modena and Reggio EmiliaCollaborator
- Holostem Terapie Avanzate s.r.l.Study director
- A.O. Ospedale Maggiore di LodiCollaborator
- Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, MilanoOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.